MCM
CRNC icon

Marathon Capital Management’s Cerence CRNC Stock Holding History

Marathon Capital Management’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,210
Closed -$222K – 187
2020
Q4 		$222K Buy
+2,210
New +$165K 0.07% 142

Other funds holding CRNC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Marathon Capital Management's CRNC Position: Q1 2021 in Review

Marathon Capital Management sold out of Cerence (CRNC) in Q1 2021, closing a stake of 2,210 shares — an estimated $222K sold.

Marathon Capital Management first reported a position in CRNC in Q4 2020 and held it in 1 quarter. The position peaked at $222K in Q4 2020. 320 funds tracked by Wall St. Rank hold CRNC as of Q1 2021.

  • Marathon Capital Management reported no remaining Cerence position as of Q1 2021 after selling out during the quarter.
  • Marathon Capital Management sold 2,210 Cerence shares in Q1 2021, an estimated $222K.
  • Marathon Capital Management first reported a position in Cerence in Q4 2020 and held it in 1 quarter.
  • Marathon Capital Management's Cerence position peaked at $222K in Q4 2020.
  • 320 funds tracked by Wall St. Rank held Cerence as of Q1 2021.

Based on Marathon Capital Management's 13F filing for Q1 2021, filed 14 May 2021.